BlackRock, Inc. 13D and 13G filings for West Pharmaceutical Services, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 5:23 pm Sale |
2023-12-31 | 13G | West Pharmaceutical Services, Inc. WST |
BlackRock Inc. BLK |
7,778,203 10.500% |
-370,421 (-4.55%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | West Pharmaceutical Services, Inc. WST |
BlackRock Inc. BLK |
8,148,624 11.000% |
54,336 (+0.67%) |
Filing |
| 2022-01-26 8:18 pm Unchanged |
2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST |
BlackRock Inc. BLK |
8,094,288 10.900% |
0 (Unchanged) |
Filing |
| 2022-01-25 11:15 am Purchase |
2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST |
BlackRock Inc. BLK |
8,094,288 10.900% |
626,479 (+8.39%) |
Filing |
| 2021-04-09 6:02 pm Purchase |
2021-03-31 | 13G | West Pharmaceutical Services, Inc. WST |
BlackRock Inc. BLK |
7,467,809 10.100% |
176,869 (+2.43%) |
Filing |
| 2021-02-01 08:30 am Sale |
2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST |
BlackRock Inc. BLK |
7,290,940 9.900% |
-867,980 (-10.64%) |
Filing |